Previous Article | Next Article ![]()
J. Virol., Jun 1997, 4495-4501, Vol 71, No. 6
O Shapira-Nahor, H Marcus, H Segall, I Lubin, S Slavin, A Panet and Y Reisner
Replication of human immunodeficiency virus type 1 (HIV-1) is regulated by
virus-encoded regulatory proteins, as well as by a variety of cellular
factors. Productive infection of human T lymphocytes by HIV-1 is dependent
upon the activation status of the target cells. In general, short-term
mitogenic stimulation of CD4 T cells is used to enhance infection of
peripheral blood mononuclear cells (PBMC) in vitro. Recently, we
demonstrated that adoptive transfer of human PBMC into lethally irradiated
BALB/c mice, radioprotected with severe combined immunodeficiency (SCID)
mouse bone marrow, leads to marked T- cell activation and proliferation. In
the present study, we investigated the effect of such xenoactivation of
human T cells on their susceptibility to HIV-1 infection. Human cells that
were recovered from human/Balb radiation chimeras supported efficient
replication of laboratory strains of HIV-1, as well as of HIV-1 clinical
isolates. The multiplicity of infection required to attain effective virus
replication in the recovered xenoactivated human cells was 10- to 100-fold
lower than that needed for infection of short- or long-term
phytohemagglutinin (PHA)-stimulated blasts or of various T- cell lines.
Analysis of human cell surface activation markers has indicated that
xenoactivation in the mouse, in contrast to in vitro stimulation with PHA,
is associated with a marked downregulation of CD25 (interleukin 2
receptor). Our results demonstrate that human cells recovered from
human/Balb radiation chimeras, which are hypersensitive to HIV-1 infection,
differ from in vitro-stimulated cells in their activation status.
Therefore, this system could be used to study host factors that participate
in HIV-1 infection and replication in vitro and in vivo.
Copyright © 1997, American Society for Microbiology
Human T cells recovered from human/Balb radiation chimeras are hypersensitive to human immunodeficiency virus type 1 infection
Department of Virology, The Hebrew University Hadassah Medical School, Jerusalem, Israel.
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|